The patient’s symptoms of menorrhagia, subfertility, and an abdominal mass strongly suggest the presence of fibroids. While ectopic pregnancy should be ruled out, it is less likely due to the absence of severe pain. Endometriosis and endometrial cancer are also unlikely causes of an abdominal mass. Although ovarian cancer cannot be completely ruled out, it is not the most probable diagnosis. Fibroids are benign tumors that commonly occur in the myometrium. Symptoms include heavy menstrual bleeding, pain (if the fibroid twists), and subfertility. As fibroids grow larger, they can cause additional symptoms such as dysuria, hydronephrosis, constipation, and sciatica. Initial treatment typically involves medications such as tranexamic acid, NSAIDs, or progesterones to manage menorrhagia, but surgery is often necessary for persistent fibroids.

Understanding Uterine Fibroids

Uterine fibroids are non-cancerous growths that develop in the uterus. They are more common in black women and are thought to occur in around 20% of white women in their later reproductive years. Fibroids are usually asymptomatic, but they can cause menorrhagia, which can lead to iron-deficiency anaemia. Other symptoms include lower abdominal pain, bloating, and urinary symptoms. Fibroids may also cause subfertility.

Diagnosis is usually made through transvaginal ultrasound. Asymptomatic fibroids do not require treatment, but periodic monitoring is recommended. Menorrhagia secondary to fibroids can be managed with various treatments, including the levonorgestrel intrauterine system, NSAIDs, tranexamic acid, and hormonal therapies.

Medical treatment to shrink or remove fibroids may include GnRH agonists or ulipristal acetate, although the latter is not currently recommended due to concerns about liver toxicity. Surgical options include myomectomy, hysteroscopic endometrial ablation, hysterectomy, and uterine artery embolization.

Fibroids generally regress after menopause, but complications such as subfertility and iron-deficiency anaemia can occur. Red degeneration, which is haemorrhage into the tumour, is a common complication during pregnancy.

For pregnant women who are at moderate or high risk of pre-eclampsia, it is recommended to take aspirin in low doses of 75-150mg daily from 12 weeks of gestation until delivery. In this case, the patient has three moderate risk factors for pre-eclampsia and should be advised to take low-dose aspirin throughout her pregnancy. While hydralazine is an alternative antihypertensive medication to labetalol in pregnancy, it is not necessary for this patient as she is not hypertensive. Labetalol is the first-line antihypertensive medication for pregnant women. Magnesium is only indicated for severe pre-eclampsia to prevent or treat seizures in patients with eclampsia, which is not present in this patient.

Pre-eclampsia is a condition that occurs during pregnancy and is characterized by high blood pressure, proteinuria, and edema. It can lead to complications such as eclampsia, neurological issues, fetal growth problems, liver involvement, and cardiac failure. Severe pre-eclampsia is marked by hypertension, proteinuria, headache, visual disturbances, and other symptoms. Risk factors for pre-eclampsia include hypertension in a previous pregnancy, chronic kidney disease, autoimmune disease, diabetes, chronic hypertension, first pregnancy, and age over 40. Aspirin may be recommended for women with high or moderate risk factors. Treatment involves emergency assessment, admission for observation, and medication such as labetalol, nifedipine, or hydralazine. Delivery of the baby is the most important step in management, with timing depending on the individual case.

Understanding Endometrial Cancer: Causes, Stages, and Treatment Options

Endometrial cancer is a type of cancer that affects the lining of the uterus. It is the most common female genital cancer in the developing world, and an estimated 3% of women in developed countries will be diagnosed with this malignancy at some point in their lifetime. Here are some key points to understand about endometrial cancer:

Causes:
– It is more common among women using progestogen-containing oral contraceptives.
– Non-hormonal uterine devices have also been found to be strongly protective.
– There are two pathogenic types of endometrial cancer, one of which is associated with obesity, hyperlipidaemia, signs of hyperoestrogenism, and other disease states.

Stages:
– The FIGO staging system is used to determine the stage of endometrial cancer.
– Staging is the most important prognostic factor.
– The earlier endometrial cancer is diagnosed, the higher the rate of survival at 5 years.

Treatment:
– Standard management of endometrial cancer at diagnosis involves surgery, followed by chemotherapy with or without radiation therapy.
– It is most effectively treated by a combination of radiotherapy and hormone-based chemotherapy.
– The prognosis varies depending on the stage and type of endometrial cancer.

Overall, understanding the causes, stages, and treatment options for endometrial cancer is important for early detection and effective management of this malignancy.

Maternal obesity with a BMI of 30 kg/m2 or more increases the risk of neural tube defects in babies. There is no strong evidence linking obesity to hyper- or hypothyroidism in neonates, an increased risk of Down syndrome, or cystic fibrosis.

Folic Acid: Importance, Deficiency, and Prevention

Folic acid is a vital nutrient that is converted to tetrahydrofolate (THF) in the body. It is found in green, leafy vegetables and plays a crucial role in the transfer of 1-carbon units to essential substrates involved in the synthesis of DNA and RNA. However, certain factors such as phenytoin, methotrexate, pregnancy, and alcohol excess can cause a deficiency in folic acid. This deficiency can lead to macrocytic, megaloblastic anemia and neural tube defects.

To prevent neural tube defects during pregnancy, it is recommended that all women take 400mcg of folic acid until the 12th week of pregnancy. Women at higher risk of conceiving a child with a neural tube defect should take 5mg of folic acid from before conception until the 12th week of pregnancy. Women are considered higher risk if they or their partner has a neural tube defect, they have had a previous pregnancy affected by a neural tube defect, or they have a family history of a neural tube defect. Additionally, women with certain medical conditions such as coeliac disease, diabetes, or thalassaemia trait, or those taking antiepileptic drugs, or who are obese (BMI of 30 kg/m2 or more) are also considered higher risk.

In summary, folic acid is an essential nutrient that plays a crucial role in DNA and RNA synthesis. Deficiency in folic acid can lead to serious health consequences, including neural tube defects. However, taking folic acid supplements during pregnancy can prevent these defects and ensure a healthy pregnancy.

If a woman on COCP misses one pill, she should take the missed pill immediately and then take the next pill at the usual time. There is no need for any further action or emergency contraception such as a copper IUD. She can continue with the 7-day pill-free break as normal. Discarding the missed pill is not recommended as it could increase the risk of an unwanted pregnancy. Starting the next pack without the 7-day break is also not necessary in this case. However, if she misses two pills and there are fewer than seven pills left in the pack, she would need to start the next pack without a break.

Missed Pills in Combined Oral Contraceptive Pill

When taking a combined oral contraceptive (COC) pill containing 30-35 micrograms of ethinylestradiol, it is important to know what to do if a pill is missed. The Faculty of Sexual and Reproductive Healthcare (FSRH) has updated their recommendations in recent years. If one pill is missed at any time in the cycle, the woman should take the last pill even if it means taking two pills in one day and then continue taking pills daily, one each day. No additional contraceptive protection is needed in this case.

However, if two or more pills are missed, the woman should take the last pill even if it means taking two pills in one day, leave any earlier missed pills, and then continue taking pills daily, one each day. In this case, the woman should use condoms or abstain from sex until she has taken pills for 7 days in a row. If pills are missed in week 1 (Days 1-7), emergency contraception should be considered if she had unprotected sex in the pill-free interval or in week 1. If pills are missed in week 2 (Days 8-14), after seven consecutive days of taking the COC there is no need for emergency contraception.

If pills are missed in week 3 (Days 15-21), the woman should finish the pills in her current pack and start a new pack the next day, thus omitting the pill-free interval. Theoretically, women would be protected if they took the COC in a pattern of 7 days on, 7 days off. It is important to follow these guidelines to ensure the effectiveness of the COC in preventing pregnancy.

Bacterial vaginosis is the identified condition, primarily caused by an overgrowth of anaerobic organisms in the vagina, with Gardnerella vaginalis being the most prevalent. This results in the displacement of lactobacilli, which would not be detected in the sample. The presence of hyphae suggests the existence of Candida (thrush).

Bacterial vaginosis (BV) is a condition where there is an overgrowth of anaerobic organisms, particularly Gardnerella vaginalis, in the vagina. This leads to a decrease in the amount of lactobacilli, which produce lactic acid, resulting in an increase in vaginal pH. BV is not a sexually transmitted infection, but it is commonly seen in sexually active women. Symptoms include a fishy-smelling vaginal discharge, although some women may not experience any symptoms at all. Diagnosis is made using Amsel’s criteria, which includes the presence of thin, white discharge, clue cells on microscopy, a vaginal pH greater than 4.5, and a positive whiff test. Treatment involves oral metronidazole for 5-7 days, with a cure rate of 70-80%. However, relapse rates are high, with over 50% of women experiencing a recurrence within 3 months. Topical metronidazole or clindamycin may be used as alternatives.

Bacterial vaginosis during pregnancy can increase the risk of preterm labor, low birth weight, chorioamnionitis, and late miscarriage. It was previously recommended to avoid oral metronidazole in the first trimester and use topical clindamycin instead. However, recent guidelines suggest that oral metronidazole can be used throughout pregnancy. The British National Formulary (BNF) still advises against using high-dose metronidazole regimes. Clue cells, which are vaginal epithelial cells covered with bacteria, can be seen on microscopy in women with BV.

Implanon and Nexplanon are subdermal contraceptive implants that slowly release the progestogen hormone etonogestrel to prevent ovulation and thicken cervical mucus. Nexplanon is the newer version and has a redesigned applicator to prevent deep insertions and is radiopaque for easier location. It is highly effective with a failure rate of 0.07/100 women-years and lasts for 3 years. It does not contain estrogen, making it suitable for women with a past history of thromboembolism or migraine. It can be inserted immediately after a termination of pregnancy. However, a trained professional is needed for insertion and removal, and additional contraceptive methods are required for the first 7 days if not inserted on days 1 to 5 of a woman’s menstrual cycle.

The main disadvantage of these implants is irregular and heavy bleeding, which can be managed with a co-prescription of the combined oral contraceptive pill. Other adverse effects include headache, nausea, and breast pain. Enzyme-inducing drugs such as certain antiepileptic and rifampicin may reduce the efficacy of Nexplanon, and women should switch to a method unaffected by enzyme-inducing drugs or use additional contraception until 28 days after stopping the treatment.

There are also contraindications for using these implants, such as ischaemic heart disease/stroke, unexplained, suspicious vaginal bleeding, past breast cancer, severe liver cirrhosis, and liver cancer. Current breast cancer is a UKMEC 4 condition, which represents an unacceptable risk if the contraceptive method is used. Overall, these implants are a highly effective and long-acting form of contraception, but they require careful consideration of the potential risks and contraindications.

When a couple is trying to conceive, it is normal for it to take up to one year for them to be successful. Therefore, medical examinations are typically conducted after one year of consistent attempts to conceive. However, it may be wise to address any physical barriers that could be hindering the couple’s ability to conceive, which is why their sexual history is taken into consideration.

Infertility is a common issue that affects approximately 1 in 7 couples. It is important to note that around 84% of couples who have regular sexual intercourse will conceive within the first year, and 92% within the first two years. The causes of infertility can vary, with male factor accounting for 30%, unexplained causes accounting for 20%, ovulation failure accounting for 20%, tubal damage accounting for 15%, and other causes accounting for the remaining 15%.

When investigating infertility, there are some basic tests that can be done. These include a semen analysis and a serum progesterone test. The serum progesterone test is done 7 days prior to the expected next period, typically on day 21 for a 28-day cycle. The interpretation of the serum progesterone level is as follows: if it is less than 16 nmol/l, it should be repeated and if it remains consistently low, referral to a specialist is necessary. If the level is between 16-30 nmol/l, it should be repeated, and if it is greater than 30 nmol/l, it indicates ovulation.

It is important to counsel patients on lifestyle factors that can impact fertility. This includes taking folic acid, maintaining a healthy BMI between 20-25, and advising regular sexual intercourse every 2 to 3 days. Additionally, patients should be advised to quit smoking and limit alcohol consumption to increase their chances of conceiving.

Expectant management of an ectopic pregnancy is only possible if the embryo is unruptured, less than 35mm in size, has no heartbeat, is asymptomatic, and has a B-hCG level of less than 1,000IU/L and is declining. However, this management option is very uncommon as most patients present with symptoms.

Ectopic pregnancy is a serious condition that requires prompt investigation and management. Women who are stable are typically investigated and managed in an early pregnancy assessment unit, while those who are unstable should be referred to the emergency department. The investigation of choice for ectopic pregnancy is a transvaginal ultrasound, which will confirm the presence of a positive pregnancy test.

There are three ways to manage ectopic pregnancies: expectant management, medical management, and surgical management. The choice of management will depend on various criteria, such as the size of the ectopic pregnancy, whether it is ruptured or not, and the patient’s symptoms and hCG levels. Expectant management involves closely monitoring the patient over 48 hours, while medical management involves giving the patient methotrexate and requires follow-up. Surgical management can involve salpingectomy or salpingotomy, depending on the patient’s risk factors for infertility.

Salpingectomy is the first-line treatment for women with no other risk factors for infertility, while salpingotomy should be considered for women with contralateral tube damage. However, around 1 in 5 women who undergo a salpingotomy require further treatment, such as methotrexate and/or a salpingectomy. It is important to carefully consider the patient’s individual circumstances and make a decision that will provide the best possible outcome.

Contraceptives – Time to become effective (if not used on the first day of period):
Immediate: IUD
2 days: Progestin-only pill (POP)
7 days: Combined oral contraceptive (COC), injection, implant, intrauterine system (IUS)

Counselling for Women Considering the Combined Oral Contraceptive Pill

Women who are considering taking the combined oral contraceptive pill (COC) should receive counselling on the potential harms and benefits of the pill. The COC is highly effective if taken correctly, with a success rate of over 99%. However, there is a small risk of blood clots, heart attacks, and strokes, as well as an increased risk of breast and cervical cancer.

In addition to discussing the potential risks and benefits, women should also receive advice on how to take the pill. If the COC is started within the first 5 days of the menstrual cycle, there is no need for additional contraception. However, if it is started at any other point in the cycle, alternative contraception should be used for the first 7 days. Women should take the pill at the same time every day and should be aware that intercourse during the pill-free period is only safe if the next pack is started on time.

There have been recent changes to the guidelines for taking the COC. While it was previously recommended to take the pill for 21 days and then stop for 7 days to mimic menstruation, it is now recommended to discuss tailored regimes with women. This is because there is no medical benefit to having a withdrawal bleed, and options include never having a pill-free interval or taking three 21-day packs back-to-back before having a 4 or 7 day break.

Women should also be informed of situations where the efficacy of the pill may be reduced, such as vomiting within 2 hours of taking the pill, medication that induces diarrhoea or vomiting, or taking liver enzyme-inducing drugs. It is also important to discuss sexually transmitted infections and precautions that should be taken with enzyme-inducing antibiotics such as rifampicin.

Overall, counselling for women considering the COC should cover a range of topics to ensure that they are fully informed and able to make an informed decision about their contraceptive options.

If the 1st repeat smear at 12 months for cervical cancer screening is now negative for hrHPV, the patient should return to routine recall, which is repeating the cervical smear in 5 years. Cytological examination of the smear is not necessary as the NHS now follows an HPV first system. Referral for colposcopy is also not indicated unless there is evidence of dyskaryosis or inadequate smears. Repeating the cervical smear in 3 years is not appropriate for a 50-year-old patient, and repeating the smear after 12 months is only necessary if the most recent smear is positive for hrHPV with no cytological abnormalities.

The cervical cancer screening program has evolved to include HPV testing, which allows for further risk stratification. A negative hrHPV result means a return to normal recall, while a positive result requires cytological examination. Abnormal cytology results lead to colposcopy, while normal cytology results require a repeat test at 12 months. Inadequate samples require a repeat within 3 months, and two consecutive inadequate samples lead to colposcopy. Treatment for CIN typically involves LLETZ or cryotherapy. Individuals who have been treated for CIN should be invited for a test of cure repeat cervical sample 6 months after treatment.

The patient has suffered a third degree perineal tear that has extended beyond the perineal mucosa and muscle, involving the EAS but not the rectal mucosa. Therefore, it is classified as a third degree tear. The appropriate course of action is to repair the tear in theatre by a clinician who is suitably trained. Repairing the tear on the ward by a midwife is not an option as it is a third degree tear. Similarly, repairing it in theatre by a clinician trained for fourth degree tears is not necessary. It is important to note that first degree tears do not require repair, but in this case, as it is a third degree tear, not repairing it would not be appropriate as it may not heal properly.

Perineal tears are a common occurrence during childbirth, and the Royal College of Obstetricians and Gynaecologists (RCOG) has developed guidelines to classify them based on their severity. First-degree tears are superficial and do not require any repair, while second-degree tears involve the perineal muscle and require suturing by a midwife or clinician. Third-degree tears involve the anal sphincter complex and require repair in theatre by a trained clinician, with subcategories based on the extent of the tear. Fourth-degree tears involve the anal sphincter complex and rectal mucosa and also require repair in theatre by a trained clinician.

There are several risk factors for perineal tears, including being a first-time mother, having a large baby, experiencing a precipitant labour, and having a shoulder dystocia or forceps delivery. It is important for healthcare providers to be aware of these risk factors and to provide appropriate care and management during childbirth to minimize the risk of perineal tears. By following the RCOG guidelines and providing timely and effective treatment, healthcare providers can help ensure the best possible outcomes for both mother and baby.

Oral metronidazole is the recommended treatment for Trichomonas vaginalis.

Understanding Trichomonas vaginalis and its Comparison to Bacterial Vaginosis

Trichomonas vaginalis is a type of protozoan parasite that is highly motile and flagellated. It is known to cause trichomoniasis, which is a sexually transmitted infection. The infection is characterized by symptoms such as offensive, yellow/green, frothy vaginal discharge, vulvovaginitis, and strawberry cervix. The pH level is usually above 4.5, and in men, it may cause urethritis.

To diagnose trichomoniasis, a wet mount microscopy is conducted to observe the motile trophozoites. The treatment for trichomoniasis involves oral metronidazole for 5-7 days, although a one-off dose of 2g metronidazole may also be used.

When compared to bacterial vaginosis, trichomoniasis has distinct differences. Bacterial vaginosis is caused by an overgrowth of bacteria in the vagina, while trichomoniasis is caused by a protozoan parasite. The symptoms of bacterial vaginosis include a thin, grayish-white vaginal discharge with a fishy odor, and a pH level above 4.5. Unlike trichomoniasis, bacterial vaginosis is not considered a sexually transmitted infection.

In conclusion, understanding the differences between trichomoniasis and bacterial vaginosis is crucial in diagnosing and treating these conditions effectively. Proper diagnosis and treatment can help prevent complications and improve overall health and well-being.

Injectable Contraceptives: Depo Provera

Injectable contraceptives are a popular form of birth control in the UK, with Depo Provera being the main option available. This contraceptive contains 150mg of medroxyprogesterone acetate and is administered via intramuscular injection every 12 weeks. It can be given up to 14 weeks after the last dose without the need for extra precautions. The primary method of action is by inhibiting ovulation, while secondary effects include cervical mucus thickening and endometrial thinning.

However, there are some disadvantages to using Depo Provera. Once the injection is given, it cannot be reversed, and there may be a delayed return to fertility of up to 12 months. Adverse effects may include irregular bleeding and weight gain, and there is a potential increased risk of osteoporosis. It should only be used in adolescents if no other method of contraception is suitable.

It is important to note that there are contraindications to using Depo Provera, such as current breast cancer (UKMEC 4) or past breast cancer (UKMEC 3). While Noristerat is another injectable contraceptive licensed in the UK, it is rarely used in clinical practice and is given every 8 weeks. Overall, injectable contraceptives can be an effective form of birth control, but it is important to weigh the potential risks and benefits before deciding on this method.

Injectable Contraceptives: Depo Provera

Injectable contraceptives are a popular form of birth control in the UK, with Depo Provera being the main option available. This contraceptive contains 150mg of medroxyprogesterone acetate and is administered via intramuscular injection every 12 weeks. It can be given up to 14 weeks after the last dose without the need for extra precautions. The primary method of action is by inhibiting ovulation, while secondary effects include cervical mucus thickening and endometrial thinning.

However, there are some disadvantages to using Depo Provera. Once the injection is given, it cannot be reversed, and there may be a delayed return to fertility of up to 12 months. Adverse effects may include irregular bleeding and weight gain, and there is a potential increased risk of osteoporosis. It should only be used in adolescents if no other method of contraception is suitable.

It is important to note that there are contraindications to using Depo Provera, such as current breast cancer (UKMEC 4) or past breast cancer (UKMEC 3). While Noristerat is another injectable contraceptive licensed in the UK, it is rarely used in clinical practice and is given every 8 weeks. Overall, injectable contraceptives can be an effective form of birth control, but it is important to weigh the potential risks and benefits before deciding on this method.

Oral labetalol is the recommended initial treatment for this woman with moderate gestational hypertension, as per the current guidelines.

Hypertension during pregnancy is a common occurrence that requires careful management. In normal pregnancies, blood pressure tends to decrease in the first trimester and then gradually increase to pre-pregnancy levels by term. However, in cases of hypertension during pregnancy, the systolic blood pressure is usually above 140 mmHg or the diastolic blood pressure is above 90 mmHg. Additionally, an increase of more than 30 mmHg systolic or 15 mmHg diastolic from the initial readings may also indicate hypertension.

There are three categories of hypertension during pregnancy: pre-existing hypertension, pregnancy-induced hypertension (PIH), and pre-eclampsia. Pre-existing hypertension refers to a history of hypertension before pregnancy or elevated blood pressure before 20 weeks gestation. PIH occurs in the second half of pregnancy and resolves after birth. Pre-eclampsia is characterized by hypertension and proteinuria, and may also involve edema.

The management of hypertension during pregnancy involves the use of antihypertensive medications such as labetalol, nifedipine, and hydralazine. In cases of pre-existing hypertension, ACE inhibitors and angiotensin II receptor blockers should be stopped immediately and alternative medications should be prescribed. Women who are at high risk of developing pre-eclampsia should take aspirin from 12 weeks until the birth of the baby. It is important to carefully monitor blood pressure and proteinuria levels during pregnancy to ensure the health of both the mother and the baby.

The procedure being performed is called an episiotomy, which can be done using various techniques. In this case, the medio-lateral approach is being used, which involves making a cut at either the 7 o’clock or 5 o’clock positions. The main reasons for performing this procedure are twofold. Firstly, it helps to prevent the vagina from tearing during childbirth, particularly in cases where the baby’s head is too large for the mother’s pelvis. By making a controlled incision, the risk of the tear extending towards the anus and surrounding muscles is reduced, which could lead to long-term problems such as fecal incontinence. Secondly, the episiotomy creates more space for the baby to pass through, making delivery easier and safer for both the mother and child.

Understanding Episiotomy

Episiotomy is a surgical procedure that involves making an incision in the posterior wall of the vagina and perineum during the second stage of labor. This procedure is done to make it easier for the baby to pass through the birth canal. The incision is made in the area between the vagina and anus, and it can be either midline or mediolateral.

Episiotomy is usually performed when the baby is in distress, and there is a need to speed up the delivery process. It can also be done to prevent tearing of the perineum, which can be more difficult to repair than an episiotomy. However, the procedure is not without risks, and it can lead to complications such as pain, infection, and bleeding.

In recent years, there has been a decline in the use of episiotomy, as studies have shown that it does not necessarily reduce the risk of tearing or improve healing time. Many healthcare providers now only perform episiotomy when it is medically necessary. It is important for expectant mothers to discuss the use of episiotomy with their healthcare provider and understand the risks and benefits before making a decision.

Malignant melanomas may be influenced by oestrogen, which plays a protective role in the skin. However, the role of oestrogens in malignant melanoma is still unclear. Oestrogen receptor β (ERβ) may distinguish melanomas linked to poor prognosis from those with a favourable course. Combined oral contraceptives have contraindications, including oestrogen-dependent neoplasia, but can be used after 5 years if there is no evidence of disease. Progesterone-only preparations can increase blood pressure and have contraindications, including a history of previous arterial or venous thrombosis. The combined pill may be preferred in patients with epilepsy, but certain anti-epileptic drugs can reduce the contraceptive effect of any type of hormonal contraception. Mechanical barriers or copper intrauterine devices may be a better option in these cases.

Post-menopausal women often experience atrophic vaginitis, which is characterized by symptoms such as vaginal dryness, dyspareunia, and occasional spotting. During examination, the vagina may appear dry and pale. Treatment options include the use of vaginal lubricants and moisturizers. If these prove ineffective, topical oestrogen cream may be prescribed.

Atrophic vaginitis is a condition that commonly affects women who have gone through menopause. Its symptoms include vaginal dryness, pain during sexual intercourse, and occasional spotting. Upon examination, the vagina may appear dry and pale. The recommended treatment for this condition is the use of vaginal lubricants and moisturizers. If these do not provide relief, a topical estrogen cream may be prescribed.

Cavernosal blood gas analysis is a crucial investigation for patients presenting with priapism. In this case, the patient has a partially erect, non-painful penis that has persisted for over 4 hours, indicating non-ischaemic priapism. This type of priapism is caused by large volume arterial inflow to the penis from trauma or congenital malformation. Confirming whether the priapism is ischaemic or non-ischaemic through cavernosal blood gas analysis is essential for appropriate management. Ischaemic priapism is a medical emergency that requires aspiration of blood from the cavernosa, while non-ischaemic priapism can be managed with observation initially. In paediatric patients, a doppler ultrasound may be a better alternative to cavernosal blood gases due to the potential trauma of the procedure.

A CT pelvis is not recommended in this case as it would expose the child to unnecessary radiation. Instead, a doppler ultrasound can be used to investigate the arterial/venous blood flow in the penis. A clotting screen may be useful if the patient has a history of bleeding problems or a family history of haemoglobinopathies. However, it should not delay cavernosal blood gas analysis as it is crucial to confirm the type of priapism. Testicular ultrasound is not a useful imaging modality for investigating priapism. If an imaging modality is required to assess penile blood flow, a doppler ultrasound is the preferred option.

Understanding Priapism: Causes, Symptoms, and Management

Priapism is a medical condition characterized by a persistent penile erection that lasts longer than four hours and is not associated with sexual stimulation. There are two types of priapism: ischaemic and non-ischaemic, each with a different pathophysiology. Ischaemic priapism is caused by impaired vasorelaxation, resulting in reduced vascular outflow and trapping of de-oxygenated blood within the corpus cavernosa. Non-ischaemic priapism, on the other hand, is due to high arterial inflow, often caused by fistula formation due to congenital or traumatic mechanisms.

Priapism can affect individuals of all ages, with a bimodal distribution of age at presentation, with peaks between 5-10 years and 20-50 years of age. The incidence of priapism has been estimated at up to 5.34 per 100,000 patient-years. There are various causes of priapism, including idiopathic, sickle cell disease or other haemoglobinopathies, erectile dysfunction medication, trauma, and drug use (both prescribed and recreational).

Patients with priapism typically present acutely with a persistent erection lasting over four hours and pain localized to the penis. A history of haemoglobinopathy or medication use may also be present. Cavernosal blood gas analysis and Doppler or duplex ultrasonography can be used to differentiate between ischaemic and non-ischaemic priapism and assess blood flow within the penis. Treatment for ischaemic priapism is a medical emergency and includes aspiration of blood from the cavernosa, injection of a saline flush, and intracavernosal injection of a vasoconstrictive agent. Non-ischaemic priapism, on the other hand, is not a medical emergency and is usually observed as a first-line option.